Dark

OSUR
OraSure Technologies Inc
stock NASDAQ

At Close

May 30, 2025 3:59:57 PM EDT

2.88USD+1.408%(+0.04)1,097,939

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-2.84)0

After-hours

May 29, 2025 4:00:30 PM EDT

2.84USD-0.351%(-0.01)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

07:29AM EST Diagnostic company OraSure Technologies, Inc. (OSUR) announced Monday that its InteliSwab COVID-19 rapid tests have been authorized by the U.S. Food and Drug Administration (FDA) for use in children ages 2 to 14. InteliSwab was previously authorized for use in adults and in children 15 to 17 when administered by an adult. RTTNews

07:15AM EST OraSure InteliSwab COVID-19 Rapid Tests Receive US FDA Authorization For Pediatric Use; Company Launches New InteliSwab Connect Reporting App Benzinga

07:14AM EST OraSure Says InteliSwab COVID-19 Rapid Tests Gets FDA Authorization For Pediatric Use RTTNews

07:05AM EST Data Demonstrates InteliSwab is Accurate, Easy to Use, and Well Accepted by Children GlobeNewswire Inc

Jan 25, 2022

07:21AM EST OraSure Technologies, Inc. Expands HIV Oral Swab In-Home Test Into Europe Benzinga

07:05AM EST OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has launched its OraQuick HIV Self-Test, an oral swab in-home test for HIV-1 and HIV-2, into Europe. The test will be available in six European countries: United Kingdom, Germany, France, Italy, Spain and Portugal. GlobeNewswire Inc

Jan 14, 2022

02:32PM EST White House Official Says May Purchase More Than 1B At-Home Tests; Says 'We're Not Stopping There;' Orders Will Be Limited To 4 Tests Per Residential Address; Tests Will Ship Within 7-12 Days Of Ordering Benzinga

Jan 13, 2022

04:09PM EST OraSure Reports Its InteliSwab COVID Rapid Tests Detect Omicron Variant As Effectively As Original Coronavirus Benzinga

04:05PM EST InteliSwab COVID-19 Rapid Tests Detect Omicron at Same GlobeNewswire Inc

Jan 11, 2022

10:44AM EST 'FDA Acting Commissioner Woodcock on rapid tests. There are now total of 15 authorized by FDA. New program in place to accelerate review of these tests.' -News Nation Reporter Benzinga

Jan 10, 2022

02:28PM EST White House Says Expects To Have All Contracts For New Rapid Test Awarded Over Next 2 Weeks Benzinga

Jan 5, 2022

01:05PM EST OraSure's CEO Resigns, Commences Review Of Strategic Alternatives Benzinga

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

07:13AM EST OraSure Sees Q4 Revenue At Low End Of Guidance Range Of ~$60M Benzinga

07:12AM EST OraSure President And CEO Stephen Tang To Leave Co. Mar. 31, 2022; Co. Has Initiated Search For Successor Benzinga

07:12AM EST OraSure Sees Q4 InteliSwab Revenue ~$12M, Sees FY InteliSwab Revenue $20M Benzinga

07:11AM EST OraSure Commences Review Of Strategic Alternatives Benzinga

07:05AM EST OraSure Technologies Announces Actions to Enhance Stockholder Value GlobeNewswire Inc

Dec 28, 2021

10:27AM EST New York City To Double In-School PCR COVID Testing When Students Return Benzinga

Dec 23, 2021

12:19PM EST White House Still Working To Finalize Contracts For US Orders Of COVID Tests; COVID Testing Stocks Quiet Benzinga

Dec 21, 2021

04:39PM EST President Biden Tweets 'Starting this week, the federal government will set up emergency testing sites in areas that need additional testing capacity. Before Christmas, the first several of these federal testing sites will be up and running in New York..' Benzinga

12:18PM EST Fauci Says President Biden To Leverage Defense Production Act To Spur 200M To 500M COVID Tests To Market Benzinga

12:17PM EST New York Attorney General Issues Post 'Attorney General James Issues Warning to LabQ Diagnostics to Stop Misrepresenting Turnaround Times for COVID-19 Test Results' Benzinga

Dec 17, 2021

11:17AM EST COVID Testing Plays Quiet Following Headline Biden Admin. Will Push For 'Test-To-Stay' Policy To Keep Kids In School Benzinga

Dec 14, 2021

07:05AM EST OraSure Technologies Announces 2022 Annual Meeting Date GlobeNewswire Inc

Dec 9, 2021

09:42PM EST 'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report Benzinga

Nov 30, 2021

07:05AM EST OraSure Technologies Remains Committed to the Global Fight Against GlobeNewswire Inc

Nov 19, 2021

07:05AM EST OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire Inc

Nov 9, 2021

07:05AM EST OraSure Technologies Announces the Retirement of Jack E. Jerrett GlobeNewswire Inc

Nov 8, 2021

07:05AM EST New Appointments Bring to the Company Significant Executive Leadership, Global Product Development, Public Health, and the Retail Pharmacy Market Experience GlobeNewswire Inc

Nov 4, 2021

07:39AM EDT OraSure Q3 Sales, Without COVID Related Products, Jump 37%; Guides FY21 Sales Below Consensus Benzinga

Nov 3, 2021

05:56PM EDT OraSure Technologies Raises FY21 Sales Guidance From ~$230M To $230M-$233M Vs. $235.9M Est. Benzinga

05:55PM EDT OraSure Technologies Q3 EPS $(0.21) Misses $(0.04) Estimate, Sales $53.92M Beat $47.48M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

Nov 2, 2021

10:50AM EDT OraSure Technologies Says FDA Authorizes InteliSwab COVID-19 Rapid Tests For OTC Single-Use, At-Home Testing For Symptomatic People; Says Accepts Data For Delta Variant Detection Benzinga

07:05AM EDT U.S. FDA Authorizes InteliSwab COVID-19 Rapid GlobeNewswire Inc

Oct 27, 2021

07:05AM EDT OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 3, 2021. GlobeNewswire Inc

Oct 6, 2021

03:11PM EDT White House COVID-19 Coordinator Zients Says U.S. Making Further $1B Investment In Testing To Buy Additional 180M Tests Benzinga

03:10PM EDT White House Advisor ZIents Says Quidel, OraSure Are Further/More Rapidly Expanding Production Of Their Tests To Get More Capacity Of The Market Benzinga

Oct 4, 2021

07:48AM EDT OraSure Technologies, Inc. (OSUR) said it has been awarded a $109 million contract from the U.S. Department of Defense to build additional manufacturing capacity for InteliSwab COVID-19 rapid tests. InteliSwab is a simple test that rapidly detects COVID-19. The company noted that the agreement is part of the nation's pandemic preparedness plan. RTTNews

07:22AM EDT OraSure Bags $109 Mln Contract To Ramp Manufacturing Of InteliSwab COVID-19 Rapid Test RTTNews

07:07AM EDT OraSure Wins $109M Department of Defense Contract to Manufacture a COVID-19 Rapid Test Benzinga

07:05AM EDT OraSure Awarded $109 Million Contract from U.S. Department of GlobeNewswire Inc

Sep 24, 2021

01:21PM EDT FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations Benzinga

Sep 23, 2021

10:00AM EDT OraSure Secures $13.6M BARDA Funding For InteliSwab COVID-19 Test 510(k) Clearance and CLIA Waiver Benzinga

08:11AM EDT OraSure Technologies Reports Will Receive U p To $13.6M From Biomedical Advanced Research Development Authority To Support InteliSwab COVID-19 Rapid Test 510(k) Clearance, Clinical Lab Improvement Amendments Waiver Benzinga

08:10AM EDT OraSure to Receive up to $13.6 Million from Biomedical Advanced GlobeNewswire Inc

Sep 22, 2021

10:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021 Benzinga

05:03AM EDT Raymond James Downgrades OraSure Technologies to Market Perform Benzinga

Sep 20, 2021

06:17AM EDT OraSure Technologies Inc. (OSUR) said that the Defense Logistics Agency has awarded the company a procurement contract for its InteliSwab COVID-19 Rapid Test for over-the-counter use, which the Defense Logistics Agency estimated to have a value of $205 million. RTTNews

06:04AM EDT OraSure Bags $205 Mln Procurement Contract For InteliSwab From Defense Logistics Agency RTTNews

06:02AM EDT OraSure Receives $205M Procurement Contract For InteliSwab From The Defense Logistics Agency To Supply Over-The-Counter Kits As Part Of National Pandemic Response Benzinga

06:00AM EDT OraSure Receives $205 Million Procurement Contract for GlobeNewswire Inc

Sep 17, 2021

01:07PM EDT OraSure Technologies Shares See Volume; Raymond James Says Co Wins $512M Contract Benzinga

Sep 2, 2021

08:40AM EDT OraSure Technologies, Inc. (OSUR), dealing in point-of-care testing and sample collection technologies, on Thursday said its Chief Financial Officer Roberto Cuca has resigned from the company effective September 17. The healthcare business firm said the resignation is to pursue other opportunities and not due to any disagreements or disputes with the company. RTTNews

07:26AM EDT OraSure Technologies CFO Roberto Cuca To Resign Effective Sept 17; Scott Gleason To Serve As Interim CFO RTTNews

07:06AM EDT OraSure Technologies Announces Resignation Of CFO Roberto Cuca; Co. Has Initiated Search For Permanent CFO Benzinga

07:00AM EDT OraSure Technologies Announces Resignation of CFO Roberto Cuca and GlobeNewswire Inc

Aug 20, 2021

01:45PM EDT Looking into OraSure Technologies's Return on Capital Employed Benzinga

Aug 4, 2021

12:04PM EDT Shares of medical device company OraSure Technologies, Inc. (OSUR) are down more than 8 percent on Wednesday's trading even as the company posted narrower loss in the second quarter but missed estimates. RTTNews

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

07:34AM EDT Raymond James Maintains Outperform on OraSure Technologies, Raises Price Target to $12.5 Benzinga

Aug 3, 2021

05:17PM EDT OraSure Technologies: Q2 Earnings Insights Benzinga

04:45PM EDT OraSure Technologies Sees Q3 Sales $45M-$50M Vs. $67.88M Est., FY21 Sales ~$230M Vs. $287.63M Est. Benzinga

04:44PM EDT OraSure Technologies Q2 EPS $(0.02) Misses $0.04 Estimate, Sales $57.61M Beat $56.69M Estimate Benzinga

04:05PM EDT OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven GlobeNewswire Inc

03:52AM EDT Earnings Scheduled For August 3, 2021 Benzinga

Jul 27, 2021

04:01PM EDT OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, August 3, 2021. GlobeNewswire Inc

Jun 28, 2021

07:28AM EDT Raymond James Maintains Outperform on OraSure Technologies, Lowers Price Target to $11 Benzinga

Jun 17, 2021

04:05PM EDT OraSure Technologies to Present at the Raymond GlobeNewswire Inc

Jun 15, 2021

10:32AM EDT Cramer Weighs In On Johnson & Johnson, ViacomCBS And More Benzinga

Jun 14, 2021

06:00AM EDT OraSure and the Will Rodgers Liver Health Foundation to Heighten GlobeNewswire Inc

Jun 7, 2021

10:38AM EDT OraSure's COVID-19 Rapid Antigen Tests Gets FDA Emergency Approval for OTC, Professional, Prescription Use Benzinga

09:19AM EDT OraSure Technologies Says Receives 3 Emergency Use Authorizations For Co's COVID-19 Rapid Antigen Tests For Non-Prescription, Professional And Prescription Use Benzinga

09:18AM EDT OraSure Technologies Receives Three Emergency Use Authorizations GlobeNewswire Inc

May 28, 2021

07:00AM EDT OraSure Technologies, Inc.(NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr.Stephen S. Tang, President and CEO, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference. The conference will be simultaneously webcast over the Internet. GlobeNewswire Inc

May 26, 2021

09:21AM EDT OraSure Resubmits EUA Applications for ELISA COVID-19 Antibody Test Benzinga

07:22AM EDT OraSure Says FDA Requested Additional Analytical Data On Sample Collection And Stability And Resubmit Separate EUAs For Antibody ELISA And The Collection Device Benzinga

May 18, 2021

07:00AM EDT OraSure Technologies, Inc.(NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr.Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference. The conference will be simultaneously webcast over the Internet. GlobeNewswire Inc

May 17, 2021

07:00AM EDT OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications effective today. GlobeNewswire Inc

May 12, 2021

06:00AM EDT OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2021 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern (7:00 a.m. Pacific) on Tuesday, May 18, 2021. GlobeNewswire Inc

May 10, 2021

06:00AM EDT Insignia and Partners Support CDC Demonstration Project for Uptake GlobeNewswire Inc

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

08:01AM EDT Raymond James Maintains Outperform on OraSure Technologies, Lowers Price Target to $12 Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

May 5, 2021

04:01PM EDT OraSure Technologies Sees Q2 Sales $55M-$60M Vs. $66.98M Est. Benzinga

04:00PM EDT OraSure Technologies Q1 EPS $0.05 Beats $0.04 Estimate, Sales $59.00M Beat $57.00M Estimate Benzinga

04:00PM EDT First Quarter 2021 Net Revenues of $59 Million Increased 85% Over 2020, Driven by $27 Million in Sales of Sample Collection Devices for COVID-19 Molecular Testing GlobeNewswire Inc

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

Apr 30, 2021

04:01PM EDT OraSure Technologies, Inc.(NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 first quarter financial results and certain business developments for5:00 pm ET(2:00 pm PT) onWednesday, May 5, 2021. GlobeNewswire Inc

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Mar 30, 2021

10:44AM EDT Return On Capital Employed Overview: OraSure Technologies Benzinga

09:20AM EDT OraSure Files Emergency Use Application For COVID-19 Kits For Home Use And Professional Test Benzinga

07:10AM EDT OraSure Submits COVID-19 Rapid Antigen Prescription Home Self, Professional Test To FDA For EUA RTTNews

07:02AM EDT OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test And Professional Test To FDA For Emergency Use Authorization Benzinga

07:00AM EDT OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its COVID-19 rapid antigen test for both Prescription Home Use, and Professional Use in point of care (POC) settings. GlobeNewswire Inc

Mar 1, 2021

04:49PM EST Recap: OraSure Technologies Q4 Earnings Benzinga

04:25PM EST OraSure Sees Q1 Net Sales $55M-$60M Benzinga

04:25PM EST OraSure Technologies Q4 EPS $0.03 Down From $0.06 YoY, Sales $62.85M Beat $57.29M Estimate Benzinga

04:15PM EST Full-Year 2020 Net Revenues of $172 Million Increased 11% Year-Over-Year, Driven by $50 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing GlobeNewswire Inc

03:51AM EST Earnings Scheduled For March 1, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 26, 2021

10:09AM EST OraSure Technologies's Earnings: A Preview Benzinga

Feb 24, 2021

04:01PM EST OraSure Technologies to Present at the Raymond James 42nd Annual GlobeNewswire Inc

Feb 18, 2021

06:00AM EST OraSure Technologies, Inc.(NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 fourth quarter financial results and certain business developments for5:00 pm ET(2:00 pm PT) onMonday, March 1, 2021. GlobeNewswire Inc

Jan 29, 2021

06:09AM EST OraSure: OM-505 Included In EUA Granted To Ambry Genetics For Use In COVID-19 RT-PCR Saliva Test RTTNews

06:01AM EST OraSure Reports Its DNA Genotek Subsidiary's OMNIgene Oral Included In Emergency Use Authorization Grant For Ambry Genetics For Use In COVID-19 RT-PCR Saliva Test Benzinga

06:00AM EST OraSure Subsidiary DNA Genoteks GlobeNewswire Inc

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

06:14AM EST OraSure Subsidiary DNA Genotek's OMNIgeneORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing Benzinga

06:00AM EST OraSure Subsidiary DNA Genoteks GlobeNewswire Inc

Jan 26, 2021

07:58AM EST OraSure's OMNIgeneORAL Saliva Collection Kit Selected By Chronomics For Use In UK Government 'Test to Release for International Travel' COVID-19 Testing Program Benzinga

07:57AM EST OraSures OMNIgeneORAL GlobeNewswire Inc

Jan 25, 2021

06:00AM EST Leading Microbiome Researcher Dr. Eric Pamer Joins GlobeNewswire Inc

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

06:07AM EST OraSure's Oragene Dx Saliva Collection Kit Included in Industry's First FDA Authorization for a Whole Exome Sequencing Platform Benzinga

06:00AM EST OraSures OrageneDx GlobeNewswire Inc

Jan 8, 2021

06:00AM EST OraSure Technologies Announces 2021 Annual Meeting Date GlobeNewswire Inc

Jan 5, 2021

06:00AM EST OraSure Technologies to Present at the 39th Annual J.P. Morgan GlobeNewswire Inc

Dec 23, 2020

06:21AM EST 3B BlackBio To Use OraSure OMNIgeneORAL RTTNews

06:01AM EST OraSure Reports Its OMNIgene ORAL Device Included In Emergency Use Authorization Amendment Granted To 3B BlackBio For SARS-CoV-2 Test Benzinga

06:00AM EST OraSures OMNIgeneORAL GlobeNewswire Inc

Dec 21, 2020

04:03PM EST OraSure Technologies Announces FDA Has Requested Additional Information As Part Of Its Review Of Co.'s EUA Application For Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test Benzinga

04:01PM EST OraSure Technologies Provides Update on Its Emergency Use GlobeNewswire Inc

Nov 30, 2020

07:00AM EST OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in the fight against HIV, today announced its plans to commemorate World AIDS Day. On Tuesday, Dec. 1st, OraSure will ring the closing bell for the NASDAQ Stock Market, in a virtual ceremony that will be livestreamed. GlobeNewswire Inc

07:00AM EST OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 2020 Evercore ISI HealthCONx Conference. The conference will be simultaneously webcast over the Internet. GlobeNewswire Inc

Nov 12, 2020

07:00AM EST OraSure Technologies to Present at the Stephens Annual Investment GlobeNewswire Inc

Nov 9, 2020

08:03AM EST Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard PR Newswire

Nov 4, 2020

04:19PM EST OraSure Technologies Sees Q4 Sales $55M-$60M Vs. $61.46M Est. Benzinga

04:17PM EST OraSure Technologies Q3 EPS $0.01 Beats $(0.07) Estimate, Sales $48.01M Beat $41.70M Estimate Benzinga

04:01PM EST Net Third Quarter Revenues of $48.0Million Increased 33% Year-Over-Year,Driven by $18.4Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing GlobeNewswire Inc

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

04:41AM EST Earnings Scheduled For November 4, 2020 Benzinga

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

07:08AM EST OraSure Reports Its DNA Genotek Subsidiary Receives FDA Emergency Use Authorization For Its ORAcollect-RNA Saliva Collection Device For SARS CoV-2 Benzinga

07:00AM EST OraSures DNA Genotek Subsidiary Receives FDA GlobeNewswire Inc

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 21, 2020

06:00AM EDT OraSure Technologies, Inc.(NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 third quarter financial results and certain business developments for5:00 pm ET(2:00 pm PT) onWednesday, November 4, 2020. GlobeNewswire Inc

Oct 19, 2020

10:28AM EDT Return On Capital Employed Overview: OraSure Technologies Benzinga

09:59AM EDT Shares of OraSure Technologies Inc. (OSUR) are soaring over 25% Monday morning, after the company announced that its DNA Genotek subsidiary has received Emergency Use Authorization or EUA from the U.S. Food and Drug Administration or FDA for the use of DNA Genotek's OMNIgeneORAL saliva collection and stabilization device in COVID-19 testing. RTTNews

06:02AM EDT OraSure's OMNIgeneORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 Benzinga

06:00AM EDT OraSures OMNIgeneORAL GlobeNewswire Inc

Sep 24, 2020

06:11AM EDT OraSure: ORAcollectRNA Device Included In EUA Granted To Quadrant For COVID-19 Test RTTNews

06:05AM EDT OraSure's Oracollect RNA Device Included In EUA Granted To Quadrant Biosciences Benzinga

06:00AM EDT OraSures ORAcollectRNA GlobeNewswire Inc

Sep 15, 2020

12:00PM EDT Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics GlobeNewswire Inc

Sep 3, 2020

04:31PM EDT OraSure's ORAcollect RNA Device Included In EUA Granted To MiraDx Inc. For SARS-CoV-2 Test Benzinga

04:30PM EDT OraSures ORAcollectRNA GlobeNewswire Inc

Aug 27, 2020

04:30PM EDT OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the following upcoming investor conferences: GlobeNewswire Inc

Aug 21, 2020

09:33AM EDT Benzinga's Top Upgrades, Downgrades For August 21, 2020 Benzinga

07:32AM EDT Evercore ISI Group Initiates Coverage On OraSure Technologies with Outperform Rating, Announces Price Target of $22 Benzinga

Aug 10, 2020

10:25AM EDT Benzinga's Top Upgrades, Downgrades For August 10, 2020 Benzinga

07:09AM EDT JP Morgan Initiates Coverage On OraSure Technologies with Neutral Rating, Announces Price Target of $18 Benzinga

06:44AM EDT Citigroup Initiates Coverage On OraSure Technologies with Buy Rating, Announces Price Target of $18 Benzinga

Aug 7, 2020

09:34AM EDT Benzinga's Top Upgrades, Downgrades For August 7, 2020 Benzinga

06:00AM EDT Raymond James Upgrades OraSure Technologies to Outperform, Announces $16 Price Target Benzinga

Aug 6, 2020

02:37PM EDT Mid-Afternoon Market Update: Dow Jumps Over 100 Points; Denali Therapeutics Shares Spike Higher Benzinga

12:02PM EDT Mid-Day Market Update: OraSure Technologies Drops Following Downbeat Q2 Results; American Virtual Cloud Technologies Shares Gain Benzinga

10:13AM EDT Mid-Morning Market Update: Markets Edge Higher; Bristol-Myers Squibb Earnings Top Estimates Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 5, 2020

04:19PM EDT OraSure Technologies Q2 EPS $(0.16) Misses $(0.09) Estimate, Sales $29.26M Miss $32.82M Estimate Benzinga

04:01PM EDT OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three and six months ended June 30, 2020. GlobeNewswire Inc

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Jul 31, 2020

12:16PM EDT OraSure's OMNIgene ORAL Device Included In EUA Granted To Clinical Reference Laboratory For Self-Collected Coronavirus Saliva Test Benzinga

12:15PM EDT OraSures OMNIgeneORAL GlobeNewswire Inc

11:29AM EDT OraSure Shares Move Higher After PR 'Clinical Reference Laboratory Receives FDA Emergency Use Authorization For Best-in-Class Self-Collected Coronavirus Saliva Test' BZ NOTE: Studies Conducted by Clinical Reference Lab And OraSure Subsidiary DNA Genotech Benzinga

11:24AM EDT Clinical Reference Laboratory Receives FDA Emergency Use Authorization for PR Newswire

Jul 22, 2020

06:00AM EDT 2020 Second Quarter Earnings Conference Call Wednesday, August 5, 2020, 5:00 p.m. ET GlobeNewswire Inc

Jul 17, 2020

01:10PM EDT U.S. Army Medical Acquisition Activity Department Intents To Award Sole Source Contract To OraSure Technologies Benzinga